Global Drug Repositioning Competitive Landscape Professional Research Report 2024

Global Drug Repositioning Competitive Landscape Professional Research Report 2024



Research Summary

Drug repositioning, also known as drug repurposing, is the process of identifying new therapeutic uses for existing drugs that were originally developed for different purposes. Rather than starting from scratch to discover and develop a new drug, drug repositioning involves investigating the potential benefits of established drugs in treating different diseases or conditions. This approach leverages existing safety and efficacy data, expediting the development timeline and potentially reducing costs. Drug repositioning involves a combination of computational analyses, laboratory experiments, and clinical studies to explore the potential of existing compounds in addressing unmet medical needs or expanding their applications beyond their initial intended uses. This strategy has gained prominence as a promising way to bring new treatments to patients more efficiently and with a higher probability of success.

According to DIResearch's in-depth investigation and research, the global Drug Repositioning market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Drug Repositioning include Teva, Novartis, Mylan, Johnson & Johnson, Pfizer, Bausch Health, GSK, Glenmark, ChemRar Group, Fujifilm, Dr. Reddy, R-Pharma etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Drug Repositioning. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Drug Repositioning market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Drug Repositioning market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Drug Repositioning industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Drug Repositioning Include:

Teva

Novartis

Mylan

Johnson & Johnson

Pfizer

Bausch Health

GSK

Glenmark

ChemRar Group

Fujifilm

Dr. Reddy

R-Pharma

Drug Repositioning Product Segment Include:

Generic Drugs

Clinical Trial Failed Drugs

Drug Repositioning Product Application Include:

Cardiovascular Diseases

Mental Illness

Cancer

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Drug Repositioning Industry PESTEL Analysis

Chapter 3: Global Drug Repositioning Industry Porter’s Five Forces Analysis

Chapter 4: Global Drug Repositioning Major Regional Market Size and Forecast Analysis

Chapter 5: Global Drug Repositioning Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Drug Repositioning Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Drug Repositioning Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Drug Repositioning Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Drug Repositioning Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Drug Repositioning Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Drug Repositioning Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Drug Repositioning Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources


1 Drug Repositioning Market Overview
1.1 Product Definition and Statistical Scope
1.2 Drug Repositioning Product by Type
1.2.1 Global Drug Repositioning Market Size by Type, 2023 VS 2024 VS 2030
1.2.2 Generic Drugs
1.2.3 Clinical Trial Failed Drugs
1.3 Drug Repositioning Product by Application
1.3.1 Global Drug Repositioning Market Size by Application, 2023 VS 2024 VS 2030
1.3.2 Cardiovascular Diseases
1.3.3 Mental Illness
1.3.4 Cancer
1.3.5 Others
1.4 Global Drug Repositioning Market Revenue Analysis (2019-2030)
1.5 Drug Repositioning Market Development Status and Trends
1.5.1 Drug Repositioning Industry Development Status Analysis
1.5.2 Drug Repositioning Industry Development Trends Analysis
2 Drug Repositioning Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 Drug Repositioning Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global Drug Repositioning Market Analysis by Regions
4.1 Drug Repositioning Overall Market: 2023 VS 2024 VS 2030
4.2 Global Drug Repositioning Revenue and Forecast Analysis (2019-2030)
4.2.1 Global Drug Repositioning Revenue and Market Share by Region (2019-2024)
4.2.2 Global Drug Repositioning Revenue Forecast by Region (2025-2030)
5 Global Drug Repositioning Market Size by Type and Application
5.1 Global Drug Repositioning Market Size by Type
5.2 Global Drug Repositioning Market Size by Application
6 North America
6.1 North America Drug Repositioning Market Size and Growth Rate Analysis (2019-2030)
6.2 North America Key Manufacturers Analysis
6.3 North America Drug Repositioning Market Size by Type
6.4 North America Drug Repositioning Market Size by Application
6.5 North America Drug Repositioning Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe Drug Repositioning Market Size and Growth Rate Analysis (2019-2030)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Drug Repositioning Market Size by Type
7.4 Europe Drug Repositioning Market Size by Application
7.5 Europe Drug Repositioning Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China Drug Repositioning Market Size and Growth Rate Analysis (2019-2030)
8.2 China Key Manufacturers Analysis
8.3 China Drug Repositioning Market Size by Type
8.4 China Drug Repositioning Market Size by Application
9 APAC (excl. China)
9.1 APAC (excl. China) Drug Repositioning Market Size and Growth Rate Analysis (2019-2030)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Drug Repositioning Market Size by Type
9.4 APAC (excl. China) Drug Repositioning Market Size by Application
9.5 APAC (excl. China) Drug Repositioning Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Indonesia
9.5.6 Vietnam
9.5.7 Malaysia
9.5.8 Thailand
10 Latin America
10.1 Latin America Drug Repositioning Market Size and Growth Rate Analysis (2019-2030)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Drug Repositioning Market Size by Type
10.4 Latin America Drug Repositioning Market Size by Application
10.5 Latin America Drug Repositioning Market Size by Country
10.5.1 Mecixo
10.5.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Drug Repositioning Market Size and Growth Rate Analysis (2019-2030)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Drug Repositioning Market Size by Type
11.4 Middle East & Africa Drug Repositioning Market Size by Application
11.5 Middle East & Africa Drug Repositioning Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Market Competition by Manufacturers
12.1 Global Drug Repositioning Market Revenue by Key Manufacturers (2020-2024)
12.2 Drug Repositioning Competitive Landscape Analysis and Market Dynamic
12.2.1 Drug Repositioning Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 Teva
13.1.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Teva Drug Repositioning Product Portfolio
13.1.3 Teva Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.2 Novartis
13.2.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Novartis Drug Repositioning Product Portfolio
13.2.3 Novartis Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.3 Mylan
13.3.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Mylan Drug Repositioning Product Portfolio
13.3.3 Mylan Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 Johnson & Johnson Drug Repositioning Product Portfolio
13.4.3 Johnson & Johnson Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.5 Pfizer
13.5.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Pfizer Drug Repositioning Product Portfolio
13.5.3 Pfizer Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.6 Bausch Health
13.6.1 Bausch Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Bausch Health Drug Repositioning Product Portfolio
13.6.3 Bausch Health Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.7 GSK
13.7.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 GSK Drug Repositioning Product Portfolio
13.7.3 GSK Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.8 Glenmark
13.8.1 Glenmark Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 Glenmark Drug Repositioning Product Portfolio
13.8.3 Glenmark Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.9 ChemRar Group
13.9.1 ChemRar Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 ChemRar Group Drug Repositioning Product Portfolio
13.9.3 ChemRar Group Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.10 Fujifilm
13.10.1 Fujifilm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 Fujifilm Drug Repositioning Product Portfolio
13.10.3 Fujifilm Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.11 Dr. Reddy
13.11.1 Dr. Reddy Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.11.2 Dr. Reddy Drug Repositioning Product Portfolio
13.11.3 Dr. Reddy Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.12 R-Pharma
13.12.1 R-Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.12.2 R-Pharma Drug Repositioning Product Portfolio
13.12.3 R-Pharma Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
14 Industry Chain Analysis
14.1 Drug Repositioning Industry Chain Analysis
14.2 Drug Repositioning Industry Raw Material and Suppliers Analysis
14.2.1 Upstream Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Drug Repositioning Typical Downstream Customers
14.4 Drug Repositioning Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings